PapersPMID:26934084
Supplementation with Watermelon Extract Reduces Total Cholesterol and LDL Cholesterol in Adults with Dyslipidemia under the Influence of the MTHFR C677T Polymorphism.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 6 weeks
- Dose studied, every finding
- 6 g watermelon extract daily for 42 days
- Population, every finding
- adults with dyslipidemia
What moved
How to read these marks →“The use of watermelon extract reduced plasma total cholesterol (p < 0.05) and low-density lipoprotein (p < 0.01) without modifying triglycerides, high-density lipoprotein, and very low-density lipoprotein values.”
- Decreases total cholesterol (TC)
very limited
- Decreases LDL cholesterol
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults with dyslipidemia, phase II randomized double-blind trial of 6 g/day watermelon extract (Citrullus lanatus) versus a carbohydrate mixture (sucrose/glucose/fructose) for 42 days, stratified by MTHFR C677T genotype. Exposure is a watermelon extract, not juice or puree. Abstract only.
- Participants
- 43
- Comparator
- placebo
- Duration
- 42 days
- Endpoints measured
- 7